Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
178.06
167.19
169.46
285.86
228.36
140.27
231.58
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
178.06
167.19
169.46
285.86
228.36
140.27
231.58
Raw Material Cost
48.66
69.62
85.23
89.44
72.54
54.91
137.26
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
55.68
65.46
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.86
1.24
0.84
8.33
18.60
22.21
22.45
Selling and Distribution Expenses
56.56
45.59
87.30
43.91
25.96
22.14
51.57
Other Expenses
-3.68
-4.20
2.18
0.40
-1.41
-1.77
-1.54
Total Expenditure (Excl Depreciation)
126.00
139.93
195.14
145.65
102.99
81.52
195.88
Operating Profit (PBDIT) excl Other Income
52.1
27.3
-25.7
140.2
125.39999999999999
58.7
35.699999999999996
Other Income
6.00
14.44
19.66
10.05
2.71
7.23
1.35
Operating Profit (PBDIT)
73.97
58.40
11.75
164.11
140.90
81.56
51.97
Interest
1.86
1.24
0.84
8.33
18.60
22.21
22.45
Exceptional Items
1.96
-0.48
-18.06
-23.51
0.11
0.00
0.00
Gross Profit (PBDT)
129.40
97.57
84.23
196.42
155.82
85.35
94.32
Depreciation
15.91
16.71
17.77
16.72
15.77
15.94
15.37
Profit Before Tax
58.15
39.98
-24.91
115.56
106.64
43.42
14.15
Tax
9.31
6.79
-4.42
20.33
17.76
9.75
-11.96
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
48.84
33.19
-20.49
95.23
88.88
33.67
26.11
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
48.84
33.19
-20.49
95.23
88.88
33.67
26.11
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
48.84
33.19
-20.49
95.23
88.88
33.67
26.11
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
654.15
709.96
693.85
849.55
209.14
-3.02
-66.78
Earnings per share (EPS)
0.24
0.16
-0.1
0.4
0.37
0.14
0.11
Diluted Earnings per share
0.24
0.16
-0.1
0.4
0.37
0.14
0.11
Operating Profit Margin (Excl OI)
29.24%
16.3%
-15.15%
48.05%
53.61%
41.63%
15.22%
Gross Profit Margin
41.59%
33.91%
-4.21%
46.27%
53.61%
42.32%
12.75%
PAT Margin
27.43%
19.85%
-12.09%
33.31%
38.92%
24.0%
11.27%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 6.52% vs -1.36% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 46.99% vs 261.95% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 54.55% vs 656.96% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 58.33% vs 50.00% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Mega Genomics Ltd. With
Figures in Million
Consolidate Annual Results
Change(HKD)
Change(%)
Net Sales
178.06
1,956.48
-1,778.42
-90.90%
Other Operating Income
0.00
0.00
0.00
Total Operating income
178.06
1,956.48
-1,778.42
-90.90%
Raw Material Cost
48.66
812.31
-763.65
-94.01%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
55.68
788.19
-732.51
-92.94%
Power Cost
0
0
0.00
Manufacturing Expenses
1.86
44.69
-42.83
-95.84%
Selling and Distribution Expenses
56.56
1,255.98
-1,199.42
-95.50%
Other Expenses
-3.68
-80.98
77.30
95.46%
Total Expenditure (Excl Depreciation)
126.00
2,091.33
-1,965.33
-93.98%
Operating Profit (PBDIT) excl Other Income
52.06
-134.85
186.91
138.61%
Other Income
6.00
-41.66
47.66
114.40%
Operating Profit (PBDIT)
73.97
165.25
-91.28
-55.24%
Interest
1.86
44.69
-42.83
-95.84%
Exceptional Items
1.96
-55.60
57.56
103.53%
Gross Profit (PBDT)
129.40
1,144.17
-1,014.77
-88.69%
Depreciation
15.91
341.76
-325.85
-95.34%
Profit Before Tax
58.15
-276.79
334.94
121.01%
Tax
9.31
-31.14
40.45
129.90%
Provisions and contingencies
0
0
0.00
Profit After Tax
48.84
-245.41
294.25
119.90%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
48.84
-245.41
294.25
119.90%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
-0.25
0.25
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
48.84
-245.65
294.49
119.88%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
654.15
760.21
-106.06
-13.95%
Earnings per share (EPS)
0.24
-0.49
0.73
148.98%
Diluted Earnings per share
0.24
-0.49
0.73
148.98%
Operating Profit Margin (Excl OI)
29.24%
-6.89%
0.00
36.13%
Gross Profit Margin
41.59%
3.32%
0.00
38.27%
PAT Margin
27.43%
-12.54%
0.00
39.97%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 17.81 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 6.52% vs -1.36% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 4.88 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 46.99% vs 261.95% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.80 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 54.55% vs 656.96% in Dec 2023
Annual - Interest
Interest 0.19 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 58.33% vs 50.00% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 29.24%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






